Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $55.38 USD
Change Today -0.74 / -1.32%
Volume 376.7K
BCPC On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 4:30 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

balchem corp (BCPC) Snapshot

Open
$55.96
Previous Close
$56.12
Day High
$55.96
Day Low
$54.23
52 Week High
12/23/14 - $69.92
52 Week Low
07/28/14 - $48.89
Market Cap
1.7B
Average Volume 10 Days
153.9K
EPS TTM
$1.71
Shares Outstanding
30.9M
EX-Date
12/24/14
P/E TM
32.4x
Dividend
$0.30
Dividend Yield
0.54%
Current Stock Chart for BALCHEM CORP (BCPC)

Related News

No related news articles were found.

balchem corp (BCPC) Related Businessweek News

No Related Businessweek News Found

balchem corp (BCPC) Details

Balchem Corp. develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries, primarily in the U.S. Its encapsulated/nutritional products segment provides solutions to various applications in food, pharmaceutical, and nutritional ingredients. It also offers human-grade choline nutrient products for wellness applications and calcium carbonate products, as well as products for the animal health industry. Its specialty products segment is a leader in packaging and distributing hazardous chemicals and is the leading supplier of packaged 100% ethylene oxide to the health-care industry, where it is used as a sterilant for medical items. The Ingredients segment manufactures and supplies choline chloride, a nutrient for animal health, to the poultry and swine industries. It also manufactures derivatives of choline chloride. Balchem was founded in 1967 and is headquartered in New Hampton, N.Y.

845 Employees
Last Reported Date: 02/27/15
Founded in 1967

balchem corp (BCPC) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $653.4K
General Counsel and Secretary
Total Annual Compensation: $204.0K
Vice President of Administration and Assistan...
Total Annual Compensation: $255.5K
Vice President and General Manager of Special...
Total Annual Compensation: $248.0K
Compensation as of Fiscal Year 2013.

balchem corp (BCPC) Key Developments

Balchem Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Balchem Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net sales were $162,668,000 against $81,633,000 a year ago. Earnings from operations were $26,995,000 against $16,145,000 a year ago. Earnings before income tax expense were $25,180,000 against $16,213,000 a year ago. Net earnings were $19,022,000 or $0.61 diluted per share against $10,747,000 or $0.35 diluted per share a year ago. Non-GAAP earnings from operations were $31,269,000 against $17,133,000 a year ago. Non-GAAP net earnings were $21,019,000 or $0.67 diluted per share against $11,402,000 or $0.37 diluted per share a year ago. EBITDA was $37,166,000 against $18,781,000 a year ago. Adjusted EBITDA was $35,582,000 against $19,711,000 a year ago. For the year, the company reported net sales were $541,383,000 against $337,173,000 a year ago. Earnings from operations were $82,143,000 against $65,602,000 a year ago. Earnings before income tax expense were $77,052,000 against $65,818,000 a year ago. Net earnings were $52,826,000 or $1.69 diluted per share against $44,874,000 or $1.45 diluted per share a year ago. Net cash provided by operating activities was $85,350,000 against $55,692,000 a year ago. Capital expenditures and intangible assets acquired were $13,367,000 against $8,377,000 a year ago. Non-GAAP earnings from operations were $107,001,000 against $69,556,000 a year ago. Non-GAAP net earnings were $68,856,000 or $2.21 diluted per share against $47,570,000 or $1.54 diluted per share a year ago. EBITDA was $112,210,000 against $76,076,000 a year ago. Adjusted EBITDA was $121,835,000 against $79,893,000 a year ago.

Balchem Mulls Acquisitions

Balchem Corp. (NasdaqGS:BCPC) is looking for acquisitions. The company stated, “We expect 2015 capital expenditures to be approximately $35 million and the Company maintains significant financial flexibility to pursue acquisitions.”

Balchem Corp. to Report Q4, 2014 Results on Feb 24, 2015

Balchem Corp. announced that they will report Q4, 2014 results at 11:00 AM, US Eastern Standard Time on Feb 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCPC:US $55.38 USD -0.74

BCPC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aceto Corp $22.00 USD -0.39
Corbion NV €17.68 EUR -0.095
CVR Partners LP $13.15 USD -0.34
LSB Industries Inc $41.33 USD +0.37
Terra Nitrogen Co LP $145.71 USD -1.09
View Industry Companies
 

Industry Analysis

BCPC

Industry Average

Valuation BCPC Industry Range
Price/Earnings 33.1x
Price/Sales 3.3x
Price/Book 4.4x
Price/Cash Flow 32.9x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BALCHEM CORP, please visit www.balchem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.